Algotec Research and Development

Algotec Research and Development is a UK-based private medical device company focused on neuromodulation for pain management. The company markets NeuroStimulator PENS therapy, a percutaneous electrical nerve stimulation technology designed as a minimally invasive option for patients with chronic neuropathic pain. Its positioning emphasizes clinical effectiveness, reduced surgical risk, and improved economic accessibility relative to more invasive neuromodulation approaches. Algotec appears to operate as a commercial-stage device manufacturer rather than a therapeutics developer, with ISO 13485-certified quality systems and an emphasis on global adoption of its pain-management platform.